Startup · $51m raised
Every investor coverage indicates participated in a round Artificial Heart Frontiers Program raised.
| Investor | Rounds | Invested |
|---|---|---|
| Medical Research Future Fund | Grant · Grant | $51,000,000 |
Companies Artificial Heart Frontiers Program acquired or merged with, per published coverage. Buying a company is not investing in one: nothing here counts in the deals column.
| Name | Role | Sources |
|---|---|---|
| Professor David Kaye | Lead | @AuManufacturing |
Stories naming Artificial Heart Frontiers Program. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
Weekly roundup of readers' top five stories: Gilmour Space's $55m Series D raise, a $50m MRFF grant for an artificial heart consortium, K-TIG entering administration, defence budget news, and Queensland's return to venture investing.
The federal MRFF has granted $50 million to the Artificial Heart Frontiers Program, a Monash-led consortium including BiVACOR, to advance a total artificial heart; the team earlier received $1 million in 2021.
Also @AuManufacturing
A consortium led by Monash University and BiVACOR won a $1 million Medical Research Future Fund grant to commercialise an Australian total artificial heart; BiVACOR had earlier closed a US$19 million Series B.